They don't have time. By the time amrn makes any money in Europe, patents are toast. Alex denner needs to sell amrn asap. Go it alone leads to bankruptcy, not greater sale
The majority of their cost cutting is coming from laying off their sales reps. The less sales reps, the less sales. The current sales will continue to erode due to the layoffs and the competition from generics. The eroding top line sales doesn't bode well for a sale of the company.
News 
Market Data 
Discover 
